Cargando…

进展期非小细胞肺癌的首过法CT灌注可重复性研究

BACKGROUND AND OBJECTIVE: The aim of this study is to explore the reproducibility of volume-based quantitative measurement of non-small cell lung cancer (NSCLC) perfusion at 64-slice CT. METHODS: Fourteen patients with proved advanced NSCLC were enrolled in this dynamic frst pass volume-based CT per...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000689/
https://www.ncbi.nlm.nih.gov/pubmed/20677648
http://dx.doi.org/10.3779/j.issn.1009-3419.2010.05.21
_version_ 1783331815098941440
collection PubMed
description BACKGROUND AND OBJECTIVE: The aim of this study is to explore the reproducibility of volume-based quantitative measurement of non-small cell lung cancer (NSCLC) perfusion at 64-slice CT. METHODS: Fourteen patients with proved advanced NSCLC were enrolled in this dynamic frst pass volume-based CT perfusion (CTP) study (8×5 mm collimation), and they underwent the second scan within 24 h. According to the longest diameters, those patients were classifed to ≤3 cm and >3 cm groups, and each group had 7 patients. Intraclass correlation coefcient (ICC) and Bland-Altman statistics were used to evaluate the reproducibility of CTP imaging. RESULTS: In both groups of advanced NSCLC, the reproducibility with BF, BV, and PS values were good (ICC >0.75 for all), but mean transit time (MT) values. For advanced NSCLC (≤3 cm), repeatability coefcient (RC) values with blood flow (BF), blood volume (BV), MT and permeability surface area product (PS) values were 56%, 45%, 114%, and 78%, respectively, and the 95% change intervals of RC were -39%-53%, -29%-62%, -83%-145%, and -57%-98%, respectively. For advanced NSCLC (>3 cm), those values were 46%, 30%, 59%, and 33%, respectively, and the 95% change intervals of RC were -48%-45%, -33%-26%, -54%-64%, and -18%-48%. CONCLUSION: Tere is greater reproducibility of tumor size >3 cm than that of ≤3 cm. BF and BV could be addressed for reliable clinical application in antiangiogenesis therapeutic monitoring with advanced NSCLC patients.
format Online
Article
Text
id pubmed-6000689
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-60006892018-07-06 进展期非小细胞肺癌的首过法CT灌注可重复性研究 Zhongguo Fei Ai Za Zhi 临床研究 BACKGROUND AND OBJECTIVE: The aim of this study is to explore the reproducibility of volume-based quantitative measurement of non-small cell lung cancer (NSCLC) perfusion at 64-slice CT. METHODS: Fourteen patients with proved advanced NSCLC were enrolled in this dynamic frst pass volume-based CT perfusion (CTP) study (8×5 mm collimation), and they underwent the second scan within 24 h. According to the longest diameters, those patients were classifed to ≤3 cm and >3 cm groups, and each group had 7 patients. Intraclass correlation coefcient (ICC) and Bland-Altman statistics were used to evaluate the reproducibility of CTP imaging. RESULTS: In both groups of advanced NSCLC, the reproducibility with BF, BV, and PS values were good (ICC >0.75 for all), but mean transit time (MT) values. For advanced NSCLC (≤3 cm), repeatability coefcient (RC) values with blood flow (BF), blood volume (BV), MT and permeability surface area product (PS) values were 56%, 45%, 114%, and 78%, respectively, and the 95% change intervals of RC were -39%-53%, -29%-62%, -83%-145%, and -57%-98%, respectively. For advanced NSCLC (>3 cm), those values were 46%, 30%, 59%, and 33%, respectively, and the 95% change intervals of RC were -48%-45%, -33%-26%, -54%-64%, and -18%-48%. CONCLUSION: Tere is greater reproducibility of tumor size >3 cm than that of ≤3 cm. BF and BV could be addressed for reliable clinical application in antiangiogenesis therapeutic monitoring with advanced NSCLC patients. 中国肺癌杂志编辑部 2010-05-20 /pmc/articles/PMC6000689/ /pubmed/20677648 http://dx.doi.org/10.3779/j.issn.1009-3419.2010.05.21 Text en 版权所有©《中国肺癌杂志》编辑部2010 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 临床研究
进展期非小细胞肺癌的首过法CT灌注可重复性研究
title 进展期非小细胞肺癌的首过法CT灌注可重复性研究
title_full 进展期非小细胞肺癌的首过法CT灌注可重复性研究
title_fullStr 进展期非小细胞肺癌的首过法CT灌注可重复性研究
title_full_unstemmed 进展期非小细胞肺癌的首过法CT灌注可重复性研究
title_short 进展期非小细胞肺癌的首过法CT灌注可重复性研究
title_sort 进展期非小细胞肺癌的首过法ct灌注可重复性研究
topic 临床研究
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000689/
https://www.ncbi.nlm.nih.gov/pubmed/20677648
http://dx.doi.org/10.3779/j.issn.1009-3419.2010.05.21
work_keys_str_mv AT jìnzhǎnqīfēixiǎoxìbāofèiáideshǒuguòfǎctguànzhùkězhòngfùxìngyánjiū
AT jìnzhǎnqīfēixiǎoxìbāofèiáideshǒuguòfǎctguànzhùkězhòngfùxìngyánjiū
AT jìnzhǎnqīfēixiǎoxìbāofèiáideshǒuguòfǎctguànzhùkězhòngfùxìngyánjiū
AT jìnzhǎnqīfēixiǎoxìbāofèiáideshǒuguòfǎctguànzhùkězhòngfùxìngyánjiū
AT jìnzhǎnqīfēixiǎoxìbāofèiáideshǒuguòfǎctguànzhùkězhòngfùxìngyánjiū